. PFP released from killer cells forms pores on the target cell membrane and induces cell lysis (Henkart, 1985; Zalman et al., 1986; Young et al., 1986b) . Recent success in the cloning of PFP cDNA (Shinkai et al., 1988a; Lichtenheld et al., 1988; Lichtenheld & Podack, 1989; Lowrey et al., 1989) has allowed the examination of mRNA expression of PFP in killer cells. In the T cell lines, PFP gene expression was ascertained in the cytotoxic T lymphocytes (CTL) and natural killer (NK) cells, but not in helper T (Th) cells (Shinkai et al., 1988a; Lichtenheld et al., 1988) .
Perforin (PFP) is a cytotoxic protein contained in the cytoplasmic granules of killer cells (Masson & Tschopp, L985; Podack et al., 1985; Young et al., 1986a) . PFP released from killer cells forms pores on the target cell membrane and induces cell lysis (Henkart, 1985; Zalman et al., 1986; Young et al., 1986b) . Recent success in the cloning of PFP cDNA (Shinkai et al., 1988a; Lichtenheld et al., 1988; Lichtenheld & Podack, 1989; Lowrey et al., 1989) has allowed the examination of mRNA expression of PFP in killer cells. In the T cell lines, PFP gene expression was ascertained in the cytotoxic T lymphocytes (CTL) and natural killer (NK) cells, but not in helper T (Th) cells (Shinkai et al., 1988a; Lichtenheld et al., 1988) .
The role of tumour infiltrating lymphocytes (TIL) in the defense mechanism of a tumour-bearing host has been thoroughly reported (Werkmeister et al., 1979) . It is known that CTL and NK cells directly kill tumour cells (Reinherz et al., 1979; Lanier et al., 1983; Lanier et al., 1986) . In human cancer tissues, PFP may be derived from CTL and NK cells and may play an important role in anti-tumour activity.
In this paper, we aimed to identify the phenotypes of human peripheral blood lymphocytes (PBL) and TIL, which produce PFP. We employed a double staining method using both anti-PFP antibody and antibodies against surface markers of lymphocytes. Furthermore, we investigated the relation of PFP and tumour progression in human colorectal cancer stroma. (Figure 1) . PFP was detected in large lymphocytes and accounted for about 10% of PBL. Preimmune rat serum or preabsorbed antibody used as a control did not yield specific staining. These control tests were repeated on the cytocentrifuged specimens of PBL with the same results. Double staining showed that 18% of CD16 + cells and 9% of CD8 + cells but none of the CD4 + cells produced PFP (Figure 2 ).
Materials and methods

Cell preparation
PFP + cells in cancer stroma
Frozen sections of 28 colorectal cancers were evaluated for PFP specific immunostaining. Figure 3 shows the results obtained. PFP immunoreactivity was observed in the lymphocytes infiltrating to the tumour stroma, especially in the vicinity of tumour infiltration, but only a little in the normal epithelia. Preimmune rat serum used as a control did not yield specific staining. These control tests were repeated on sections of TIL with the same results.
The mean numbers of PFP + cells which were counted in three fields on each specimen were indicated with a dot in Figure 4 . The number of PFP + cells in Dukes A was 19.0 ± 7.1 (mean ± s.d.), in Dukes B 8.9 ± 4.5 (mean ± s.d.), and in Dukes C 3.2 ± 2.1 (mean ± s.d.). The number of PFP + cells in Dukes A was significantly higher than in Dukes B (P <0.01), and that in Dukes B significantly higher than in Dukes C (P <0.01). Furthermore, the number in Dukes A was significantly much higher than in Dukes C (P <0.001). The populations of PFP + cells were determined with double staining. A part of the CD16 + cells and CD8 + cells was doubly stained by anti PFP antibody but CD4 + cells were not doubly stained in TIL ( Figure 5 ). PFP + cells in CD8 + and CD16 + cells were counted. The ratios of PFP + cells in CD8 + cells and in CD16 + cells were highest in Dukes A, while the number of PFP + cells decreased according to the progression of tumours. In all stages, the ratio of PFP + cells in CD8 + cells was higher than that in CD16 + cells (Figure 6 ).
Discussion
Northern blot analysis has confirmed that PFP is expressed by human CTL and NK cells in vitro (Shinkai et al., 1988a; Lichtenheld et al., 1988) , but the expression of this protein in vivo has not yet been shown. In this study, we first investigated PFP + cells and their phenotypes in circulating PBL by double staining, using both a rat anti-PFP monoclonal antibody which cross-reacts to human PFP (Nakata et al., 1990) (Rabinowich et al., 1987) .
Many investigators have reported that the number of CD8 + cells or CD16 + cells in TIL tends to decrease in advanced cancer (Shinokawara et al., 1982; Ogata et al., 1989) , and several factors which show the cytotoxicity against cancer cells have been characterised (Young & Cohn, 1987; Tschopp & Jongeneel, 1988 
